To utilise AI and ML for the prevention of avoidable blindness in children
LV Prasad Eye Institute and CognitiveCare announced a partnership to jointly pursue efforts that advance the early detection of eye diseases and adverse eye conditions in infants and children. The partnership combines LV Prasad Eye Institute’s world-renowned expertise and research in eye health with CognitiveCare’s AI platform, which incorporates granular insights and patterns that interplay with clinical and social determinants to quantify propensity for health risks at individual and population levels early.
“We are happy to partner with CognitiveCare and are confident that our combined expertise in clinical management and machine learning will help us accelerate the early diagnosis of ROP and Myopia in young children and infants. We are also hopeful that this partnership will pave the way to leverage AI, deep learning, and advanced computational sciences to address several other critical eye diseases,” said Dr Prashant Garg, Executive Chair, LV Prasad Eye Institute.
“Alongside our partners at the LV Prasad Eye Institute, we aim to support healthcare constituents in understanding propensity for eye conditions early enough to prevent adverse outcomes, including blindness in infants and myopia in children,” said Sheena Gill, President and CEO, Americas for CognitiveCare.
“Our models will provide explainable AI functionality to help caregivers understand the ‘why’ behind each eye health score. Healthy eyes still elude millions of children globally. Eye health complications in infancy and childhood continue to impact long-term health and well-being. We can now prevent certain adverse eye health outcomes with early detection and intervention,” stated Dr Suresh Attili, Co-founder, CognitiveCare.
